COSMO PHARMACEUTICALS NV (C43.DE) Stock Income Statement
FRA:C43 - Deutsche Boerse Ag - NL0011832936 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 185.36M | 92.78M | 102.09M | 65.07M | 60.95M | |||
| Minority Interest Expense | -267.00K | -200.00K | -280.00K | -1.00K | 0.00 | |||
| Cost Of Goods | 43.62M | 39.34M | 40.49M | 32.98M | 27.62M | |||
| Gross Profit | 141.74M | 53.44M | 61.60M | 32.10M | 33.33M | |||
| Operating Expenses | 55.76M | 47.29M | 33.54M | 21.00M | 30.43M | |||
| Research and Development | 21.35M | 14.75M | 11.55M | 7.60M | 13.60M | |||
| Selling, General, and Administrative Expenses | 36.45M | 29.94M | 19.91M | 10.46M | 18.68M | |||
| Operating Income | 85.98M | 6.15M | 28.06M | 11.10M | 2.90M | |||
| Interest Income/Expense | 704.00K | -4.50M | -3.47M | 13.38M | -13.67M | |||
| Other Income/Expense | -74.00K | -118.00K | -113.00K | -481.00K | -168.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | 4.00M | |||
| Income Before Taxes | 86.61M | 1.53M | 24.47M | 24.00M | -6.93M | |||
| Income Tax | 16.77M | 6.26M | 6.97M | 2.33M | 970.00K | |||
| Net Income | 69.57M | -4.93M | 17.23M | 21.67M | -7.90M | |||
| EBITDA | 100.62M | 20.41M | 41.91M | 18.47M | 8.94M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 4.32 | -0.31 | 1.05 | 1.28 | -0.55 | |||
| Non GAAP EPS | N/A | N/A | 1.05 | N/A | -0.55 | |||
| Statistics | ||||||||
| Gross Profit Margin | 76.47% | 57.60% | 60.34% | 49.32% | 54.69% | |||
| Profit Margin | 37.53% | -5.32% | 16.87% | 33.30% | -12.96% | |||
| Operating Profit Margin | 46.38% | 6.62% | 27.48% | 17.06% | 4.77% | |||
All data in EUR